संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

dr.reddy's laboratories inc - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 5 mg in 100 ml - zoledronic acid injection is indicated for treatment of paget's disease of bone in men and women. treatment is indicated in patients with paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ]. zoledronic acid injection is contraindicated in patients with the following conditions:   - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ]. - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see adverse reactions (6.2) ] . pregnancy category d [see warnings and precautions (5.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

par pharmaceutical companies, inc. - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 5 mg in 100 ml - zoledronic acid injection is indicated for treatment of paget's disease of bone in men and women. treatment is indicated in patients with paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ]. zoledronic acid injection is contraindicated in patients with the following conditions: - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ]. - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see post-marketing experience (6.2) ]. pregnancy category d [see warnings and precautions

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 5 mg in 100 ml - zoledronic acid injection is indicated for treatment of paget's disease of bone in men and women. treatment is indicated in patients with paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ]. zoledronic acid injection is contraindicated in patients with the following conditions: - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ]. - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see adverse reactions (6.2) ]. pregnancy category d [see warnings and precautions (5.6) ].

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

akorn - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 5 mg in 100 ml - zoledronic acid injection is indicated for treatment of paget's disease of bone in men and women. treatment is indicated in patients with paget's disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ]. zoledronic acid injection is contraindicated in patients with the following conditions: - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ] - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see adverse reactions (6.2) ]. pregnancy category d [see warnings and precautions (5.6) ].

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

deseret biologicals, inc. - adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), pantothenic acid (unii: 19f5hk2737) (pantothenic acid - unii:19f5hk2737), sus scrofa pineal gland (unii: 050qz2edk7) (sus scrofa pineal gland - unii:050qz2edk7), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), ubidecarenone (unii: ej27x76m46) (ubidecarenone - unii:ej27x76m46), melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl), pyrrole (unii: 86s1zd6l2c) (pyrrole - unii:86s1z - adenosine triphosphate disodium 8 [hp_x] - for temporary reduction of the symptoms of sleeplessness such as tiredness, fatigue, and lack of energy.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary reduction of the symptoms of sleeplessness such as tiredness, fatigue, and lack of energy.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

deseret biologicals, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), acetaldehyde (unii: go1n1zpr3b) (acetaldehyde - unii:go1n1zpr3b), prasterone (unii: 459ag36t1b) (prasterone - unii:459ag36t1b), phlorizin (unii: cu9s17 - ascorbic acid 6 [hp_x] in 1 ml - for temporary relief of symptoms related to high blood sugar including dry mouth, thirst, night sweats, sugar and carb cravings.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to high blood sugar including dry mouth, thirst, night sweats, sugar and carb cravings.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

eugia us llc - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 5 mg in 100 ml - zoledronic acid injection is indicated for treatment of paget’s disease of bone in men and women. treatment is indicated in patients with paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease [see clinical studies (14.5) ] . zoledronic acid is contraindicated in patients with the following conditions: - hypocalcemia [see warnings and precautions (5.2) ] - creatinine clearance less than 35 ml/min and in those with evidence of acute renal impairment due to an increased risk of renal failure [see warnings and precautions (5.3) ] . - known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported [see adverse reactions (6.2) ] . risk summary available data on the use of zoledronic acid in p

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

neopharma inc - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9), clavulanate potassium (unii: q42omw3at8) (clavulanic acid - unii:23521w1s24) - to reduce the development of drug‑resistant bacteria and maintain the effectiveness of augmentin (amoxicillin/clavulanate potassium) and other antibacterial drugs, augmentin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. augmentin®  is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below*:  caused by beta‑lactamase–producing isolates of haemophilus influenzae and moraxella catarrhalis .  caused by beta‑lactamase–producing isolates of h. influenzae and m. catarrhalis .  caused by beta‑lactamase–producing isolates of h. influenzae and m. cat

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

ecolab inc. - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9), pelargonic acid (unii: 97seh7577t) (pelargonic acid - unii:97seh7577t) - directions: pla-16 concentrate must be diluted before use do not mix with anything but cool, potable water for use only in a dispensing system recommended by ecolab pre-dipping dilution parameters: a dilute solution of a 0.5% lactic acid, 1.0% dodecyl benzene sulfonic acid and 0.1% pelargonic acid teat dip will consist of 1 part pla-16 concentrate and 9 parts potable water by volume. post dipping dilution parameters: a dilute solution of a 0.5% lactic acid, 1.0% dodecyl benzene sulfonic acid and 0.1% pelargonic acid teat dip with additive will consist of 1 part eco-flex additive with 12.50 parts water and 1.50 parts pla-16 concentrate by volume. important: never use concentrated product on teats. once concentrated teat dip product has been properly diluted, do not further dilute with water or mix with any other teat dips. if product in dip cup becomes visibly dirty, discard contents and replenish with fresh product. do not reuse or return any unused product to the original container. udder prep: when usin

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

deseret biologicals, inc. - cynanchum vincetoxicum root (unii: 9r858u917w) (cynanchum vincetoxicum root - unii:9r858u917w), echinacea angustifolia whole (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), pork liver (unii: 6ec706hi7f) (pork liver - unii:6ec706hi7f), pork kidney (unii: x7bci5p86h) (pork kidney - unii:x7bci5p86h), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), gamboge (unii: 7556hj7587) (gamboge - unii:7556hj7587), graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), 7-oxodehydroepiandrosterone 3-acetate (unii: 84rq0xom11) (7-oxodehydroepiandrosterone 3-acetate - unii:84rq0xom11), adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), insulin pork (unii: avt680jb39) (insulin pork - unii:avt680jb39), sus scrofa pancreas (unii: 9y3j3362ry) (sus scrofa pancreas - unii:9y3j3362ry), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), proteus vulgaris (unii: 11t9hco30o) (proteus vulgaris - unii:11t9hco30o) - 7-oxo-dehydroepiandrosterone 3-acetate – fat metabolism support, adenosinum triphosphoricum dinatrum – weight support, asclepias vincetoxicum – weight support, echinacea (angustifolia) – increased appetite, gambogia – fat metabolism support, graphites – stress support, hepar suis – increased appetite, hypothalamus suis – increased appetite, insulinum (suis) – fat metabolism support, kidney (suis) – stress support, methylcobalamin – weight support, nux vomica – increased appetite, pancreas suis – fat metabolism support, phytolacca decandra – stress support, proteus (vulgaris) – weight support, sarcolacticum acidum – stress support • for the temporary relief of symptoms including: • weight support • increased appetite • stress support • fat metabolism support these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.